Table I.
Characteristic | High BORIS expression, FPKM>0.0035, n | Low BORIS expression FPKM<0.0035, n | P-value |
---|---|---|---|
Sex | 0.0011 | ||
Male | 57 | 37 | |
Female | 21 | 41 | |
Race | 0.75 | ||
White | 63 | 59 | |
Black | 5 | 6 | |
Asian | 0 | 1 | |
Not reported | 11 | 11 | |
Age, years | >0.999 | ||
>62 | 38 | 39 | |
≤62 | 38 | 39 | |
Stage | 0.35 | ||
I | 17 | 14 | |
II | 41 | 37 | |
III | 16 | 23 | |
IV | 2 | 4 | |
Not reported | 2 | 0 |
Sex, ethnicity, age and stage of the 156 patients with NSCLC were grouped according to the BORIS expression level. The average level of BORIS in the 156 patients with NSCLC was 0.0035 FPKM. Data were assessed using the χ2 test. BORIS, Brother of Regulator of Imprinted Sites; NSCLC, non-small cell lung cancer; FPKM, fragments per kilobase of exon model per million reads mapped.